Medical Packaging and Labeling Services

The contract encompasses the packaging, labeling, and kitting of Trazodone tablets in strict compliance with U.S. Defense Logistics Agency, military, and Food and Drug Administration standards. All processes must adhere to hazardous material handling protocols and meet the Medical Marking Standard No. 1 requirements, ensuring proper identification, safety, and traceability throughout the supply chain. The work is subject to rigorous regulatory oversight and demands precision in documentation, labeling accuracy, and contamination control to support federal medical distribution systems. This subcontract, issued under NAICS code 325991 by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, is open for proposal through May 19, 2026, with a public posting date of May 13, 2026. While the exact place of performance and point of contact are not specified, the nature of the work implies a highly regulated manufacturing or contract packaging facility capable of handling controlled pharmaceuticals under federal military protocols. The contract does not designate a set-aside type, indicating it is open to all qualified bidders, and all responses must demonstrate full alignment with DLA and FDA guidelines for pharmaceutical distribution.